190 related articles for article (PubMed ID: 12498768)
21. Beta + thalassemia: aberrant splicing results from a single point mutation in an intron.
Busslinger M; Moschonas N; Flavell RA
Cell; 1981 Dec; 27(2 Pt 1):289-98. PubMed ID: 6895866
[TBL] [Abstract][Full Text] [Related]
22. Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations.
Suter D; Tomasini R; Reber U; Gorman L; Kole R; Schümperli D
Hum Mol Genet; 1999 Dec; 8(13):2415-23. PubMed ID: 10556289
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.
Phanthong P; Borwornpinyo S; Kitiyanant N; Jearawiriyapaisarn N; Nuntakarn L; Saetan J; Nualkaew T; Sa-Ngiamsuntorn K; Anurathapan U; Dinnyes A; Kitiyanant Y; Hongeng S
Stem Cells Transl Med; 2017 Apr; 6(4):1059-1069. PubMed ID: 28213976
[TBL] [Abstract][Full Text] [Related]
24. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.
Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW
Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459
[TBL] [Abstract][Full Text] [Related]
25. RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice.
Svasti S; Suwanmanee T; Fucharoen S; Moulton HM; Nelson MH; Maeda N; Smithies O; Kole R
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1205-10. PubMed ID: 19164558
[TBL] [Abstract][Full Text] [Related]
26. Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.
Krainer AR; Maniatis T; Ruskin B; Green MR
Cell; 1984 Apr; 36(4):993-1005. PubMed ID: 6323033
[TBL] [Abstract][Full Text] [Related]
27. Implication of globin gene expression, hemoglobin F and hemoglobin E levels on β-thalassemia/Hb E disease severity.
Siriworadechkul S; Jindadamrongwech S; Chuncharunee S; Aupparakkitanon S
Ann Clin Lab Sci; 2014; 44(4):437-42. PubMed ID: 25361929
[TBL] [Abstract][Full Text] [Related]
28. [Update on RNA splicing repair: applications to beta thalassemia and other perspectives].
Labie D; Kaplan JC
Med Sci (Paris); 2010 Jan; 26(1):38-41. PubMed ID: 20132773
[No Abstract] [Full Text] [Related]
29. Role of alternatively spliced beta E-globin mRNA on clinical severity of beta-thalassemia/hemoglobin E disease.
Winichagoon P; Fucharoen S; Wilairat P; Chihara K; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():241-5. PubMed ID: 8629114
[TBL] [Abstract][Full Text] [Related]
30. Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation.
Vadolas J; Nefedov M; Wardan H; Mansooriderakshan S; Voullaire L; Jamsai D; Williamson R; Ioannou PA
J Biol Chem; 2006 Mar; 281(11):7399-405. PubMed ID: 16421096
[TBL] [Abstract][Full Text] [Related]
31. [The regulation effect of liposomal transfection of antisense oligonucleotide on the alpha-globin in patients with severe beta-thalassemia].
Liu RR; Ma J; Chen P; Mo WN; Lin WX; Lai YR
Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):385-9. PubMed ID: 19951531
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization by antisense oligonucleotides of exon and intron sequences required for splicing.
Dominski Z; Kole R
Mol Cell Biol; 1994 Nov; 14(11):7445-54. PubMed ID: 7935459
[TBL] [Abstract][Full Text] [Related]
33. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
34. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
Mercatante DR; Sazani P; Kole R
Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
[TBL] [Abstract][Full Text] [Related]
35. Nuclear degradation of nonsense mutated beta-globin mRNA: a post-transcriptional mechanism to protect heterozygotes from severe clinical manifestations of beta-thalassemia?
Kugler W; Enssle J; Hentze MW; Kulozik AE
Nucleic Acids Res; 1995 Feb; 23(3):413-8. PubMed ID: 7885837
[TBL] [Abstract][Full Text] [Related]
36. Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia.
Maquat LE; Kinniburgh AJ; Rachmilewitz EA; Ross J
Cell; 1981 Dec; 27(3 Pt 2):543-53. PubMed ID: 6101206
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
38. RNA therapeutics for β-thalassemia.
Duong HQ; Nguyen TH; Hoang MC; Ngo VL; Le VT
Prog Mol Biol Transl Sci; 2024; 204():97-107. PubMed ID: 38458745
[TBL] [Abstract][Full Text] [Related]
39. Correlation of BACH1 and Hemoglobin E/Beta-Thalassemia Globin Expression.
Lee TY; Muniandy L; Teh LK; Abdullah M; George E; Sathar J; Lai MI
Turk J Haematol; 2016 Mar; 33(1):15-20. PubMed ID: 26377036
[TBL] [Abstract][Full Text] [Related]
40. Quantification analysis of splice signal sequences: mutation of 3'-splice signal sequence and mechanism of unsplicing in a beta-thalassemia pre-mRNA.
Iida Y
Nucleic Acids Symp Ser; 1999; (42):63-4. PubMed ID: 10780380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
